Effective One‐for‐All Phototheranostic Agent for Hypoxia‐Tolerant NIR‐II Fluorescent/PA Image‐Guided Phototherapy
Small · 2025
DOI: 10.1002/smll.202406226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Simin Xi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, P. R. China. Hauptthemen laut MEDLINE: Photoacoustic Techniques, Phototherapy, Theranostic Nanomedicine, Infrared Rays. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, Knowledge Innovation Program of Wuhan-Shuguang Project.
Abstract (Originalsprache)
Near‐infrared (NIR)‐triggered type‐I photosensitizers are crucial to address the constraints of hypoxic tumor microenvironments in phototherapy; however, significant challenges remain. By selecting an electron‐deficient unit, a matched energy gap in the upper‐level state is instrumental in boosting the efficiency of intersystem crossing for the type‐I electron transfer process. 2‐Cyanothiazole, an electron acceptor, is covalently linked with N , N ‐diphenyl‐4‐(thiophen‐2‐yl)aniline to yield a multifunctional photosensitizer (TTNH) that exhibits intrinsic NIR absorbance and compatible T 2 energy levels, facilitating both radiative and nonradiative transitions. The prepared nanoparticles (TTNH NPs) assembled from TTNH are activated by an 808 nm laser and generated the O 2 • − for hypoxia‐tolerant type‐I photodynamic therapy under both normoxia and hypoxic conditions. TTNH NPs emitted NIR‐II fluorescence with an impressive NIR‐II fluorescence quantum yield of 2.08%. With a high photothermal conversion efficiency of 51.8% under 808 nm laser stimulation, TTNH NPs exhibit photothermal therapy performance, accompanied by enhanced photoacoustic imaging capability owing to their strong NIR absorption. These characteristics make TTNH an effective NIR‐wavelength‐triggered phototheranostic agent that outperforms NIR‐II fluorescence/photoacoustic dual‐model imaging‐guided type‐I photodynamic therapy/photothermal therapy against hypoxic tumors. This results provide valuable insight for developing high‐performance NIR‐II‐emissive superoxide radical phototheranostic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, P. R. China.
- Key Laboratory of Optoelectronic Chemical Materials and Devices (Ministry of Education), Flexible Display Materials and Technology Co-Innovation Centre of Hubei Province, School of Optoelectronic Materials & Technology,…
- Department of Emergency Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China.
- School of Optoelectronic Engineering, Guangdong Polytechnic Normal University, Guangzhou, 510665, P. R. China.
ORCID-Profile: Liwen Hu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- Knowledge Innovation Program of Wuhan-Shuguang Project
- Department of Natural Resources of Guangdong Province
- Excellent Discipline Cultivation Project of Jianghan University
Zitieren
APA
Xi, S., Xiao, H., Duan, Z., Li, L., Chen, J., Hu, T., Li, X., Hu, L., & Liu, R. (2025). Effective One‐for‐All Phototheranostic Agent for Hypoxia‐Tolerant NIR‐II Fluorescent/PA Image‐Guided Phototherapy. Small. https://doi.org/10.1002/smll.202406226
Vancouver
Xi S, Xiao H, Duan Z, Li L, Chen J, Hu T, et al. Effective One‐for‐All Phototheranostic Agent for Hypoxia‐Tolerant NIR‐II Fluorescent/PA Image‐Guided Phototherapy. Small. 2025. doi:10.1002/smll.202406226
BibTeX
@article{Xi2025,
author = {Xi, Simin and Xiao, Huichun and Duan, Zeyu and Li, Lie and Chen, Jian and Hu, Tianze and Li, Xiang and Hu, Liwen and Liu, Ruiyuan},
title = {Effective One‐for‐All Phototheranostic Agent for Hypoxia‐Tolerant NIR‐II Fluorescent/PA Image‐Guided Phototherapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202406226}
}
EUVIMED